211 related articles for article (PubMed ID: 22274575)
1. Integration of monitoring technology for heart failure.
Clarke B; Howlett J
Curr Opin Cardiol; 2012 Mar; 27(2):130-6. PubMed ID: 22274575
[TBL] [Abstract][Full Text] [Related]
2. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
[TBL] [Abstract][Full Text] [Related]
3. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
[TBL] [Abstract][Full Text] [Related]
4. Implantable hemodynamic monitors.
Tallaj JA; Singla I; Bourge RC
Cardiol Clin; 2011 May; 29(2):289-99. PubMed ID: 21459250
[TBL] [Abstract][Full Text] [Related]
5. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
Small RS
Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
[TBL] [Abstract][Full Text] [Related]
6. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
Cowie MR; Conraads V; Tavazzi L; Yu CM;
J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
[TBL] [Abstract][Full Text] [Related]
8. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
Yamokoski LM; Haas GJ; Gans B; Abraham WT
Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
[TBL] [Abstract][Full Text] [Related]
9. Implantable hemodynamic monitors.
Tallaj JA; Singla I; Bourge RC
Heart Fail Clin; 2009 Apr; 5(2):261-70. PubMed ID: 19249694
[TBL] [Abstract][Full Text] [Related]
10. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
[TBL] [Abstract][Full Text] [Related]
11. Fundamentals of intrathoracic impedance monitoring in heart failure.
Wang L
Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
[TBL] [Abstract][Full Text] [Related]
12. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial.
Adamson PB; Gold MR; Bennett T; Bourge RC; Stevenson LW; Trupp R; Stromberg K; Wilkoff BL; Costanzo MR; Luby A; Aranda JM; Heywood JT; Baldwin HA; Aaron M; Smith A; Zile M
Congest Heart Fail; 2011; 17(5):248-54. PubMed ID: 21906250
[TBL] [Abstract][Full Text] [Related]
13. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
Andriulli J
Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
[TBL] [Abstract][Full Text] [Related]
14. Integration of remote monitoring of device diagnostic parameters into a multidisciplinary heart failure management program.
Dierckx R; Houben R; Goethals M; Verstreken S; Bartunek J; Saeys R; De Proft M; Boel E; Vanderheyden M
Int J Cardiol; 2014 Apr; 172(3):606-7. PubMed ID: 24507743
[No Abstract] [Full Text] [Related]
15. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
[TBL] [Abstract][Full Text] [Related]
16. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.
Smith SA; Abraham WT
Congest Heart Fail; 2011; 17(5):220-6. PubMed ID: 21906246
[TBL] [Abstract][Full Text] [Related]
17. The role of implantable sensors for management of heart failure.
Kadhiresan K; Carlson G
Stud Health Technol Inform; 2004; 108():219-27. PubMed ID: 15718650
[TBL] [Abstract][Full Text] [Related]
18. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
[TBL] [Abstract][Full Text] [Related]
19. [Early warning system for pulmonary fluid status monitoring in terminal heart failure].
Wedekind H; Möller K
Dtsch Med Wochenschr; 2007 Mar; 132(11):555-9. PubMed ID: 17342631
[TBL] [Abstract][Full Text] [Related]
20. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
